Bristol-Myers Shares Outstanding

BMY -  USA Stock  

USD 66.47  0.30  0.45%

The fundamental analysis module provides a way for investors to measures Bristol-Myers Squibb's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and variouse microeconomic indicators and financial ratios related to Bristol-Myers Squibb stock. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search Shares Outstanding 

 
Refresh

Bristol-Myers Shares Outstanding Analysis

Bristol-Myers Squibb's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
 2018 2019 2020 2021 (projected)
Receivables5.35 B7.68 B8.5 B9.17 B
Inventories1.2 B4.29 B2.07 B1.8 B
Shares Outstanding 
 = 
Public Shares 
Repurchased 
More About Shares Outstanding | All Equity Analysis

Current Bristol-Myers Squibb Shares Outstanding

    
  2.23 B  
Most of Bristol-Myers Squibb's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bristol-Myers Squibb is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Bristol-Myers Shares Outstanding Driver Correlations

Understanding the fundamental principles of building solid financial models for Bristol-Myers Squibb is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Shares Outstanding. Since Bristol-Myers Squibb's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bristol-Myers Squibb's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bristol-Myers Squibb's interrelated accounts and indicators.

Bristol-Myers Shares Outstanding Historical Pattern

Today, most investors in Bristol-Myers Squibb Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Bristol-Myers Squibb's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Bristol-Myers Squibb shares outstanding as a starting point in their analysis.
 Bristol-Myers Squibb Shares Outstanding 
Share
      Timeline 
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Compare to competition

Based on the latest financial disclosure, Bristol-Myers Squibb has 2.23 B of shares currently outstending. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The shares outstanding for all United States stocks is notably lower than that of the firm.

Bristol-Myers Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bristol-Myers Squibb's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bristol-Myers Squibb could also be used in its relative valuation, which is a method of valuing Bristol-Myers Squibb by comparing valuation metrics of similar companies.
Bristol-Myers Squibb is rated fifth in shares outstanding category among related companies.

Bristol-Myers Squibb Current Valuation Drivers

We derive many important indicators used in calculating different scores of Bristol-Myers Squibb from analyzing Bristol-Myers Squibb's financial statements. These drivers represent accounts that assess Bristol-Myers Squibb's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Bristol-Myers Squibb's important valuation drivers and their relationship over time.
201620172018201920202021 (projected)
Net Income Per Employee177.79 K42.49 K211.16 K114.63 K(297.2 K)(305.02 K)
Revenue Per Employee774.96 K876.62 K968.28 K871.5 K1.4 M1.51 M
Average Assets33.04 B33.47 B33.61 B69.34 B125.34 B135.24 B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA6.25 B5.95 B6.58 B6.7 B3.49 B4.55 B
Earnings Before Interest Taxes and Depreciation Amortization USD6.25 B5.95 B6.58 B6.7 B3.49 B4.55 B
Earnings before Tax5.87 B5.16 B5.94 B4.95 B(6.89 B)(7.07 B)
Average Equity15.27 B13.91 B13.2 B25.13 B46.75 B50.44 B
Enterprise Value101.06 B104.1 B86.74 B99.05 B165.69 B141.59 B
Free Cash Flow1.84 B4.22 B6.12 B7.37 B13.3 B14.35 B
Invested Capital19.08 B18.46 B17.14 B59.57 B61.74 B66.62 B
Invested Capital Average19.88 B20.14 B17.63 B36.27 B55.9 B60.31 B
Market Capitalization97.67 B100.3 B84.84 B104.58 B140.17 B125.7 B
Tangible Asset Value25.45 B25.48 B27.36 B43.49 B44.69 B39.85 B
Working Capital4.86 B5.29 B7.06 B11.05 B11.11 B9.52 B

Bristol-Myers Fundamentals

About Bristol-Myers Squibb Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bristol-Myers Squibb's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bristol-Myers Squibb using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bristol-Myers Squibb based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol-Myers Squibb operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 30250 people.

Bristol-Myers Squibb Investors Sentiment

The influence of Bristol-Myers Squibb's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bristol-Myers. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - BMY

Bristol-Myers Squibb Investor Sentiment

Predominant part of Macroaxis users are currently bullish on Bristol-Myers Squibb. What is your opinion about investing in Bristol-Myers Squibb? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pair Trading with Bristol-Myers Squibb

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bristol-Myers Squibb position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol-Myers Squibb will appreciate offsetting losses from the drop in the long position's value.

Bristol-Myers Squibb Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Bristol-Myers Squibb and Grifols SA. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Bristol-Myers Squibb Piotroski F Score and Bristol-Myers Squibb Altman Z Score analysis. Note that the Bristol-Myers Squibb information on this page should be used as a complementary analysis to other Bristol-Myers Squibb's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Bristol-Myers Squibb Stock analysis

When running Bristol-Myers Squibb price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
The market value of Bristol-Myers Squibb is measured differently than its book value, which is the value of Bristol-Myers that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol-Myers Squibb's value that differs from its market value or its book value, called intrinsic value, which is Bristol-Myers Squibb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol-Myers Squibb's market value can be influenced by many factors that don't directly affect Bristol-Myers Squibb underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol-Myers Squibb's value and its price as these two are different measures arrived at by different means. Investors typically determine Bristol-Myers Squibb value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol-Myers Squibb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.